Efficacy and cardiovascular safety of lasmiditan in patients with cardiovascular risk factors: A systematic review and meta-analysis with updated synthesis of triptan safety data.

Reyvow (lasmiditan) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42723270

Anagha Shankar; C Fasil; Dhruv Gehlot; Ganji Ushodaya; Hira A Natarajan; I M Khalid Reza; Jieun Youn; Masoud Altabawi; Nand Gopal Bajaj; Shankar Biswas; Shivalika Singh; Sindhu Vasireddy; Yashasvi Srivastava; Zoya Hussain

Sep 12, 2026